Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by CancerSlayer

V.TLT

RE:RE:RE:"impressive, paradigm shifting, photodynamic therapy"

No Ph 3 needed....just a more extended Ph 2 is how I interpret Dr. Uddin'...

February 23, 2023

V.TLT

RE:"impressive, paradigm shifting, photodynamic therapy"

Eoganacht wrote: Research Capital sees Theralase’s Ruvidar NMIBC potential...

February 23, 2023

V.TLT

RE:RE:RE:RE:BTD

I agree Enrique... Any persistent/prolonged IR is an indication to me that...

February 22, 2023

V.TLT

RE:Question

BlueFranky wrote: If you look at the table in the presentation Eog posted...

February 20, 2023

V.TLT

RE:RE:RE:RE:RE:ASCO Presentation - 28% CR at 450 Days

Eoganacht wrote: Two months ago Ferring Pharmaceuticals received FDA...

February 20, 2023

V.TLT

RE:RE:" Missing 18 Pending patients data"

CancerSlayer wrote: wildbird1 wrote: Like almost everybody on this board, I...

February 12, 2023

V.TLT

RE:" Missing 18 Pending patients data"

wildbird1 wrote: Like almost everybody on this board, I have always thought...

February 12, 2023

V.TLT

RE:RE:RE:RE:RE:Higher efficacy numbers soon?

Legit62 wrote: CancerSlayer well said and i completely agree with your...

February 11, 2023

V.TLT

RE:RE:RE:Higher efficacy numbers soon?

ScienceFirst wrote: They cannot cherry-pick but they could probably start...

February 10, 2023

V.TLT

RE:RE:RE:RE:TLT is slowly starting to MOVE into that SWEET SPOT!

Camphikefish wrote: SF, where do you see us in a year with all you know and...

February 4, 2023

V.TLT

RE:RE:RE:Quick poll

Good points...forgot about the impact of medical tourism.  Seems like a...

February 2, 2023

V.TLT

RE:Quick poll

  I think an expedited approval in whatever form is almost a foregone...

February 2, 2023

V.TLT

RE:RE:RE:RE:RE:excellent ! Excellent ! NEWS

enriquesuave wrote: Ongoing trials can provide up to date data, but not...

February 2, 2023

V.TLT

RE:RE:RE:excellent ! Excellent ! NEWS

blackjack0 wrote: Very encouraging that they are sharing their data at this...

February 2, 2023

V.TLT

RE:RE:JV vs Buyout

ScienceFirst wrote: No.   Many biotechs have deals with different big...

February 1, 2023

V.TLT

RE:RE:RE:RE:RE:The Head, The Heart and The Gut

  A tremendous amount of value has been created on a shoestring budget...

January 31, 2023

V.TLT

RE:RE:RE:RE:The Head, The Heart and The Gut

Rumpl3StiltSkin wrote: tdon1229 wrote: OTOH, I'm not looking forward to...

January 31, 2023

V.TLT

RE:RE:The future (after NMIBC)

Rumpl3StiltSkin wrote: DJDawg wrote: While all of us look forward to the...

January 29, 2023

V.TLT

RE:RE:The Implications of TLD1433 PDT Approval for NMIBC Patients

I recall reading that Adstiladrin would be commercially available in the 2nd...

January 28, 2023

V.TLT

RE:FDA Approval for TLD1433 pdt almost certain IMHO

I have presented these lackluster CR%s, & if you look closely, patients...

January 27, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Canada Jetlines Operations Ltd

Canada Jetlines Operations Ltd N.CJET

Canada Jetlines Operations Ltd. is a Canada-based leisure-focused air carrier. The Company's principal business activities ... view more »